You can buy or sell RARX and other stocks, options, ETFs, and crypto commission-free!
Ra Pharmaceuticals, Inc. Common Stock, also called Ra Pharmaceuticals, is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. Read More It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
— per share
Expected May 7, Pre-Market